Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Transcription and Chromatin UK 2025

Transcription and Chromatin UK unites the UK’s vibrant transcription and epigenetics community with leading international experts to explore the latest developments in gene regulation. Topics [...]

The BioChemical Society Early Career Symposium 2025

The Early Career Symposium is a dedicated event focused on key professional development themes for researchers at the early stages of their careers, including late-stage [...]

Go to Top